Australian company Starpharma (ASX:SPL) has announced a new development and option agreement with AstraZeneca to progress the development of a Dendrimer Enhanced Product version of one of the UK company's oncology medicines. …
Latest Video
New Stories
-
The COVID-19 vaccine manufacturing and supply deals
September 24, 2020 - - Latest News -
BIO's Joe Damond: US sending industry a signal about pricing in other markets
September 24, 2020 - - Latest News -
New white paper highlights need for action on AMR
September 24, 2020 - - Latest News -
Flu vax: An opportunity to enhance targeted communication
September 24, 2020 - - Latest News -
New report finds Australia lagging on obesity care
September 24, 2020 - - Latest News -
Patient complaint triggers human rights intervention in PHARMAC
September 23, 2020 - - Latest News -
High profile PBS-listed medicines impacted by US executive order
September 23, 2020 - - Latest News